Acquired HIV drug resistance and virologic monitoring in a HIV hyper-endemic setting in KwaZulu-Natal Province, South Africa

[1] Rhee S-Y(2020)Virological failure and acquired genotypic resistance associated with contemporary antiretroviral treatment regimens Open Forum Infect Dis 7 ofaa316-e25227

[2] Clutter D(2019)Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort J Int AIDS Soc 22 e25227-245

[3] Hare CB(2018)Dolutegravir resistance mutations: Lessons from monotherapy studies Curr Opin Infect Dis 31 237-488

[4] Tchakoute CT(2016)Effect of dolutegravir functional monotherapy on HIV-1 virological response in integrase strand transfer inhibitor resistant patients Antivir Ther 21 481-34

[5] Sainani K(2020)Delays in repeat HIV viral load testing for those with elevated viral loads: a national perspective from South Africa J Int AIDS Soc 23 e25542-219

[6] Fessel WJ(2019)Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000–2016: a pooled sequence analysis EClinicalMedicine 9 26-240

[7] Mondi A(2017)HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa J Antimicrob Chemother 72 210-1012

[8] Cozzi-Lepri A(2011)Drug resistance and viral tropism in HIV-1 subtype C-infected patients in KwaZulu-Natal, South Africa: Implications for future treatment options J Acquir Immune Defic Syndr 58 233-1830

[9] Tavelli A(2013)High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa PLoS ONE 8 e72152-539

[10] Rusconi S(2010)Outcomes after virologic failure of first-line ART in South Africa AIDS 24 1007-1618

[1] Rhee S-Y(2020)Virological failure and acquired genotypic resistance associated with contemporary antiretroviral treatment regimens Open Forum Infect Dis 7 ofaa316-e25227

[2] Clutter D(2019)Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort J Int AIDS Soc 22 e25227-245

[3] Hare CB(2018)Dolutegravir resistance mutations: Lessons from monotherapy studies Curr Opin Infect Dis 31 237-488

[4] Tchakoute CT(2016)Effect of dolutegravir functional monotherapy on HIV-1 virological response in integrase strand transfer inhibitor resistant patients Antivir Ther 21 481-34

[5] Sainani K(2020)Delays in repeat HIV viral load testing for those with elevated viral loads: a national perspective from South Africa J Int AIDS Soc 23 e25542-219

[6] Fessel WJ(2019)Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000–2016: a pooled sequence analysis EClinicalMedicine 9 26-240

[7] Mondi A(2017)HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa J Antimicrob Chemother 72 210-1012

[8] Cozzi-Lepri A(2011)Drug resistance and viral tropism in HIV-1 subtype C-infected patients in KwaZulu-Natal, South Africa: Implications for future treatment options J Acquir Immune Defic Syndr 58 233-1830

[9] Tavelli A(2013)High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa PLoS ONE 8 e72152-539

[10] Rusconi S(2010)Outcomes after virologic failure of first-line ART in South Africa AIDS 24 1007-1618